हिंदी में पढ़ें

Home
/Cipla

Cipla

Apollo Hospital closes as top gainer for 2nd day, Cipla ends around 1% lower; Analyst expects Nifty all-time high in next day or two

Apollo Hospital closes as top gainer for 2nd day, Cipla ends around 1% lower; Analyst expects Nifty all-time high in next day or two

Thu, November 24, 2022

Correction in Cipla stock, despite 12% consolidated net profit increase in Q2FY23

Correction in Cipla stock, despite 12% consolidated net profit increase in Q2FY23

Mon, November 7, 2022

Cipla Share: Correction in pharma stock despite 12% consolidated net profit increase in Q2

Cipla Share: Correction in pharma stock despite 12% consolidated net profit increase in Q2

Mon, November 7, 2022

Cipla Q2FY23 Results: Net profit up 12% Rs 797 crore

Cipla Q2FY23 Results: Net profit up 12% Rs 797 crore

Fri, November 4, 2022

Stock Market Today 03 October 2022: Top Gainers and Losers - What investors should know

Stock Market Today 03 October 2022: Top Gainers and Losers - What investors should know

Mon, October 3, 2022

Nifty Pharma outperforms benchmarks, up 2%; Cipla, Sun Pharma hit 52-week highs

Nifty Pharma outperforms benchmarks, up 2%; Cipla, Sun Pharma hit 52-week highs

Mon, October 3, 2022

RECOMMENDED

Cipla business plan: Drug major betting big on digitisation and emerging segments

Cipla business plan: Drug major betting big on digitisation and emerging segments

Sun, August 7, 2022

Cipla, Zydus Wellness, Torrent Pharma surge up to 5%, What Brokerages recommend

Cipla, Zydus Wellness, Torrent Pharma surge up to 5%, What Brokerages recommend

Mon, August 1, 2022

Pharma stocks in focus: Cipla, Zydus Wellness, Torrent Pharma surge up to 5% after healthy Q1 results – brokerages recommend this

Pharma stocks in focus: Cipla, Zydus Wellness, Torrent Pharma surge up to 5% after healthy Q1 results – brokerages recommend this

Mon, August 1, 2022

Q1 Results FY2023: NTPC, Cipla, Emami, Exide Industries, EIH announce June quarter results - highlights

Q1 Results FY2023: NTPC, Cipla, Emami, Exide Industries, EIH announce June quarter results - highlights

Fri, July 29, 2022

brokerage report of this week brokerage bullish on top 5 pharma stocks check latest list here

brokerage report of this week brokerage bullish on top 5 pharma stocks check latest list here

Fri, July 22, 2022

Cipla to invest Rs 26 crore in GoApptiv to raise stake to 22%

Cipla to invest Rs 26 crore in GoApptiv to raise stake to 22%

Tue, June 28, 2022

Global View: Hindustan Unilever, Cipla, Infosys and JSW Steel shares can give 12-35% return – know what brokerages say

Global View: Hindustan Unilever, Cipla, Infosys and JSW Steel shares can give 12-35% return – know what brokerages say

Mon, June 6, 2022

Cipla Share Price: After company reports healthy March quarter numbers, brokerages turn bullish on stock; recommend buy

Cipla Share Price: After company reports healthy March quarter numbers, brokerages turn bullish on stock; recommend buy

Wed, May 11, 2022

Q4 Results 2022: Cipla, Max Financial Services, Torrent Power, Ajanta Pharma, Welspun India declare March quarter results; see key highlights

Q4 Results 2022: Cipla, Max Financial Services, Torrent Power, Ajanta Pharma, Welspun India declare March quarter results; see key highlights

Tue, May 10, 2022

Cipla Q4 results 2022 Preview: March quarter results on Tuesday; here is what to expect from company earnings, stock

Cipla Q4 results 2022 Preview: March quarter results on Tuesday; here is what to expect from company earnings, stock

Mon, May 9, 2022

Cipla Q4 Results Preview: How will be the results? Watch Here

Cipla Q4 Results Preview: How will be the results? Watch Here

Mon, May 9, 2022

Pharma Stocks in Focus: Alkem Lab & IPCA Lab among 4 stocks that may benefit most from 10.8% hike in drugs from April 1

Pharma Stocks in Focus: Alkem Lab & IPCA Lab among 4 stocks that may benefit most from 10.8% hike in drugs from April 1

Thu, March 31, 2022

DGGI acts on pharma companies for GST evasion; Dr Reddy's, Glenmark, Aurobindo Pharma, Mylan and Cipla come under hammer

DGGI acts on pharma companies for GST evasion; Dr Reddy's, Glenmark, Aurobindo Pharma, Mylan and Cipla come under hammer

Wed, March 30, 2022

Value Pick: Strong India franchise, rich product pipeline makes Cipla shares lucrative; brokerages see 15% upside

Value Pick: Strong India franchise, rich product pipeline makes Cipla shares lucrative; brokerages see 15% upside

Mon, March 14, 2022

4
5
6
7
8

Top News